Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma

Figure 9

The K-M survival analysis suggested that the predicted outcome of GILncSig was better than that of TP53 mutation status. (a) The K-M analysis of HCC patients with TP53 mutation and TP53 wild, and the OS in the TP53 wild group was significantly higher than the TP53 mutation group. (b) The K-M analysis of the TP53 wild/high-risk group and the TP53 wild/low-risk group, and the OS in the TP53 wild/low-risk group was significantly higher than the TP53 wild/high-risk group. (c) The K-M analysis of the TP53 mutation/high-risk group and TP53 mutation/low-risk group. The TP53 mutation/low-risk group’s OS was significantly higher than the TP53 mutation/high-risk group. (d) The K-M analysis of the TP53 mutation/high-risk group and TP53 wild/high-risk group, and there was no significant difference between the two groups. (e) The K-M analysis of TP53 mutation/low-risk group and TP53 wild/low-risk group, and there was no significant difference between the two groups. (f) The K-M analysis of all four groups, and there were significant differences between the four groups.

(a)

(b)

(c)

(d)

(e)

(f)